Health
5 myths about schizophrenia, according to a mental health expert: ‘Huge stigma’
About 1% of Americans, or nearly 3.5 million people, are affected by schizophrenia — yet the mental disorder remains highly stigmatized and misunderstood, experts say.
The reason, according to Brooke Kempf, a psychiatric mental health nurse practitioner based in Indiana, is a general lack of knowledge about schizophrenia.
“People may see somebody hallucinating and think, ‘That is schizophrenia,’ when there’s so much more to the illness,” she told Fox News Digital in an interview.
STUDY LINKS CANNABIS ABUSE TO SCHIZOPHRENIA IN YOUNG MEN
“It’s important for people to recognize that schizophrenia is a diagnosed and treatable medical condition.”
For World Schizophrenia Day, Kempf shared some of the most common myths and misconceptions surrounding the disorder.
Approximately 1% of Americans, or nearly 3.5 million people, are affected by schizophrenia — yet the mental disorder remains highly stigmatized and misunderstood, experts say. (iStock)
Here’s a look at five.
Myth No. 1: People with schizophrenia are violent
One of the greatest and “most harmful” myths is the notion that people living with schizophrenia are “scary” or “violent,” Kempf said.
“There is a long history of conflating TV or movie characters who are behaving in odd, confusing or frightening ways with a diagnosis of schizophrenia,” she said.
NY WOMAN REVEALS LIFE WITH A SISTER’S SCHIZOPHRENIA, WRITES ‘LOVE LETTER’ TO HER
“However, we have to remember that these are made-up, dramatized situations. A diagnosis of schizophrenia doesn’t have anything to do with what we see on the screen.”
When patients with schizophrenia experience an acute episode — perhaps having delusions or hearing voices — they might behave differently than they typically would, sometimes seeming angry or violent.
“The person is likely experiencing something within themselves that they might be arguing about or responding to, but they aren’t targeting anything toward another person,” Kempf said.
When a patient with schizophrenia is experiencing an acute episode — perhaps having delusions or hearing voices — they might behave differently than they typically would, sometimes seeming angry or violent. (iStock)
When symptoms are managed with medication, “you would probably have no idea of their diagnosis,” she noted.
“Through my long history of working in community mental health and hearing their stories, I know that people living with schizophrenia are good, caring, loving people,” Kempf said.
“They are more likely,” she added, “to be the victim of a violent crime than the perpetrator of one.”
Myth No. 2: People with schizophrenia have multiple personalities
There is a misconception that people with schizophrenia have multiple personalities, which could be because the Greek word “schizophrenia” means “split mind,” Kempf noted.
“However, people with schizophrenia do not have split personalities,” she said.
MORE THAN HALF OF THOSE WITH MENTAL ILLNESS DON’T GET NEEDED CARE
“They might have different behavioral characteristics when they’re ill and experiencing an episode, but it’s not because they have a split personality.”
Myth No. 3: People with schizophrenia are not intelligent
This assumption is completely false, according to Kempf.
“If the illness isn’t well managed and continues to progress, or they have repeated relapses, patients will lose gray matter in their brains, and their cognitive function may decline,” she told Fox News Digital.
“But that does not mean they’re not intelligent.”
One expert said she’s worked with a multitude of “very successful individuals who also happen to live with schizophrenia.” (iStock)
Some patients may experience cognitive decline in the early stages of the disease — referred to as the “prodromal phase,” Kempf said — but early diagnosis and intervention can help prevent that.
Kempf said she has worked with a multitude of “very successful individuals who also happen to live with schizophrenia.”
“People with schizophrenia do not have split personalities.”
In many cases, she noted, people can no longer see the “highly intelligent individual” behind the disease.
“As long as individuals with schizophrenia get the proper treatment — ideally with a long-acting injectable (LAI) medication — they can keep their symptoms controlled and function very well,” Kempf said.
Myth No. 4: Symptoms of schizophrenia only involve hallucinations and delusions
Schizophrenia consists of what is clinically termed “positive” and “negative” symptoms, Kempf noted.
“Delusions and hallucinations, as well as changes in behavior and thoughts, are considered positive symptoms,” she said.
“Delusions and hallucinations, as well as changes in behavior and thoughts, are considered positive symptoms” of schizophrenia, the expert said. (iStock)
Patients experiencing these symptoms may hear voices or have extra thoughts, delusions or fixed false beliefs, the expert explained.
“Hallucinations are not just hearing voices,” Kempf said. “They can occur in multiple ways based on our senses — seeing, hearing, smelling or feeling things.”
Negative symptoms are when people lose interest in the world around them, withdraw or don’t take an interest in everyday social interactions, according to Kempf.
DISRUPTED SLEEP, PLUS NIGHTMARES COULD BE LINKED TO AUTOIMMUNE DISEASES, EXPERTS SAY
“Patients with schizophrenia may get labeled as ‘lazy,’ or they don’t seem as put together,” she said. “But it’s not about laziness. The person’s brain doesn’t connect these things as being important.”
People with schizophrenia may also experience what are referred to as “psychomotor” symptoms, Kempf said — they might seem abnormally slow, and their speech and thought processes can be somewhat delayed or disorganized.
“Unfortunately, if these negative symptoms continue and there isn’t treatment, they can impact cognitive functioning.”
Myth No. 5: People with schizophrenia require long-term or lifelong hospitalization
Hospitalization for a person experiencing acute schizophrenia symptoms is usually very short, according to Kempf.
“For someone having an episode of schizophrenia, the average length of stay may be about five days.”
“In an inpatient setting, for someone having an episode of schizophrenia, the average length of stay may be about five days,” she said.
“If a patient doesn’t respond to medication and can’t function safely on their own, they might have to go to a longer-term, higher-level setting.”
CHICAGO NURSE IS FINALLY FREE OF COVID-19-RELATED PTSD AND DEPRESSION AFTER ELECTRICAL BRAIN TAPPING THERAPY
Today, health care providers aim to give people with schizophrenia community-based services so that they’re able to function on their own, Kempf noted.
This might mean supporting them with employment services and housing opportunities to ensure that they have an affordable and safe place to live.
“Some patients continue to live with their family members; some might live in a group home,” Kempf said.
“People living with this disease deserve to be treated like human beings and with the same care we would provide someone diagnosed with a physical illness.”
From a medical perspective, schizophrenia has different levels of severity, the expert noted.
“But, again, if managed well, with early intervention, an individual can remain high-functioning and live independently,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Our goal is the least structured environment possible, enabling the person to live a normal life where they can work, grocery shop and drive on a day-to-day basis.”
Ultimately, Kempf said, schizophrenia should be viewed as a disease, not a choice.
“While schizophrenia is a mental health diagnosis, it should be thought of no differently than a physical health diagnosis of diabetes, heart disease or kidney disease,” an expert said. (iStock)
“While schizophrenia is a mental health diagnosis, it should be thought of no differently than a physical health diagnosis of diabetes, heart disease or kidney disease,” she said.
“It just impacts a different organ: the brain.”
Other brain disorders, such as epilepsy, tend to be more accepted by society, she said — but there is still a “huge stigma” surrounding diseases like schizophrenia, “probably because of the fear of the unknown.”
“It is treatable, and both medication and support services are available,” she told Fox News Digital.
“We all have a role to play in helping to dispel myths, foster understanding and reduce stigma,” she continued.
“People living with this disease deserve to be treated like human beings and with the same care we would provide someone diagnosed with a physical illness.”
For more Health articles, visit www.foxnews.com/health.
Since the age of 13, Joseph Kowalsky has harbored a fascination with life after death, pondering ways to extend his existence indefinitely.
Today, Kowalsky, now 59, is among some 2,000 individuals who have signed up with the Cryonics Institute in Clinton Township, Michigan, betting on a future where death is not the end.
Chilling prospect of immortality
Cryonics, the process at the heart of Kowalsky’s hopes, involves preserving human bodies at ultra-low temperatures in the anticipation that future science will one day revive them.
MEN’S ENERGY AND VITALITY PLUMMETS FOR 6 REASONS. BOOST IT BACK UP THIS WAY
Shortly after a person dies, organizations like the Cryonics Institute use a heart-lung resuscitator, circulate a medical-grade antifreeze in the blood and suspend the body in aluminum pods filled with liquid nitrogen.
Dennis Kowalski, current president of the Cryonics Institute (and no relation to Joseph Kowalsky), told Fox News that over 250 individuals are currently in “suspension” at the Michigan facility.
Cryonics involves preserving human bodies at ultra-low temperatures in the anticipation that future science will one day revive them. (Cryonics Institute)
Could defying death be affordable?
The Cryonics Institute is just one player in a burgeoning industry.
Alcor, the world’s oldest cryonics company, which is based in Scottsdale, Arizona, boasts a state-of-the-art facility where more than 200 individuals are preserved.
MEDITERRANEAN DIET COULD HELP WOMEN LIVE LONGER, HARVARD STUDY FINDS
For those opting for whole-body preservation, the price tag is $200,000, while brain-only preservation costs $80,000.
Alcor CEO James Arrowood dispels the notion that cryonics is solely for the wealthy, highlighting that many clients use life insurance policies to cover costs.
Over 250 individuals are currently in “suspension” at the Michigan facility, the president of the Cryonics Institute told Fox News. (Cryonics Institute)
“About 80% of people who sign up are middle-class,” Arrowood told Fox News.
He pointed out that the clientele includes notable figures such as baseball legend Ted Williams, whose head and body were cryopreserved separately.
Skeptics cast doubt
Critics dismiss cryonics as speculative and unproven, labeling it an “iceberg scheme” lacking scientific backing.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“It’s a sad case of people being beguiled by a very understandable dream of resurrection,” Clive Coen of King’s College London told Fox News.
The neuroscience professor raised concerns over the damage inflicted during the preservation and revival process, warning that “there will be billions of mini-strokes in every millimeter of brain tissue” due to the inability of antifreeze to traverse the brain’s complex landscape.
Hope springs eternal for death defiers
There is currently no scientific evidence or successful case of a human being revived from a cryonically preserved state.
For those opting for whole-body preservation, the price tag is $200,000, while brain-only preservation costs $80,000. (Cryonics Institute)
Despite the skepticism, Joseph Kowalsky, who formerly worked with the Cryonics Institute, remains undeterred.
“Worst-case scenario, I’m still dead … And the upside? It could be a potentially life-saving medical technique,” he said.
For more Health articles, visit www.foxnews/health
As science and ethics continue to grapple with the implications of cryonics, individuals like Kowalsky illustrate a deep-seated hope for defying mortality, one frozen body at a time.
Andres del Aguila and Griff Jenkins contributed to this report.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as effective.
In a study led by Dr. Irl B. Hirsch, M.D., medical director of the Diabetes Care Center of the University of Washington Medical Center, an inhaled form of insulin — similar to an asthma inhaler — worked just as well as injections or pumps to control type 1 diabetes.
The research was presented last week at the American Diabetes Association (ADA)’s 84th Scientific Sessions in Orlando, Florida.
EATING YOGURT COULD HELP PREVENT ONE COMMON DISEASE, ACCORDING TO THE FDA
The clinical trial tested a product called Afrezza, an inhaled insulin made by MannKind Corporation in California.
Afrezza, the only inhaled insulin on the market, has been available since getting FDA approval in June 2014.
An inhaled form of insulin worked just as well as injections or pumps to control type 1 diabetes in a recent study. (iStock/MannKind)
Benefits of a third option
“In those with type 1 diabetes, insulin is required for survival,” Hirsch told Fox News Digital in an interview.
“With continuous glucose sensing, glucose control has been dramatically improved — but not everyone reaches the target with multiple injections or pumps, and there are many pros and cons with each therapy,” he said.
EATING ONE TYPE OF FRUIT REGULARLY COULD REDUCE DIABETES RISK IN WOMEN, STUDY SUGGESTS: ‘INCREDIBLY HEALTHY’
With pumps, people must wear the device, which can lead to skin problems.
They also have to purchase extra accessories.
Blood glucose levels can also drop with exercise, Hirsch warned, which can be problematic.
Afrezza, an inhaled insulin pictured here, is made by MannKind Corporation in California. (MannKind)
“Injections overall can be more convenient for some, but they don’t do as well as pump patients,” he said.
With Afrezza, the product is inhaled into the lungs before meals, and the fast-acting insulin minimizes the glucose spike often seen after eating, Hirsch noted.
“Patients with type 1 diabetes should consider this as another option for their mealtime insulin, and talk to their doctor about this choice.”
During the 17-week study, researchers evaluated the results of 141 adults who were assigned to either use the Afrezza inhaler or continue with traditional methods of injection or pump delivery.
At the 17-week mark, all participants switched to the inhaler for another 13 weeks.
Dr. Irl B. Hirsch, M.D., medical director of the Diabetes Care Center of the University of Washington Medical Center, led the new study. (MannKind)
All groups were assessed with continuous glucose monitoring at the start of the study, at 17 weeks and again at 30 weeks.
Among the inhaled insulin group, 30% of participants reached their target glucose levels (less than 7% blood sugar) compared to 17% of the people using injections and pumps.
There was no difference in hypoglycemia (low blood sugar) between the groups.
UTAH MOM FIGHTS FOR HER DAUGHTER’S ACCESS TO DISCONTINUED DIABETES MEDICATION: ‘LIFE-SAVING’
“In general, there was no difference in our primary endpoint, HbA1c, a reflection of average blood sugar,” Hirsch said.
“But that alone is misleading — many patients did better with their glucose control, while others did worse.”
With Afrezza, the product is inhaled into the lungs before meals, and the fast-acting insulin minimizes the glucose spike often seen after eating, a doctor said. (MannKind)
“The point is, inhaling insulin isn’t for everyone, but some did better than they did on their pumps.”
The people who saw the best results inhaled insulin between meals and at bedtime, Hirsch added.
At the end of the study, more than half of the participants said they would opt to stay on the inhaled insulin therapy.
“The biggest takeaway is that patients with type 1 diabetes should consider this as another option for their mealtime insulin, and talk to their doctor about this choice,” he recommended.
‘Adds value’
The American Diabetes Association acknowledged the promise of the study findings in an email to Fox News Digital.
“We look forward to our Scientific Sessions every year to see data like the INHALE-3 study’s findings, which have the potential to expand diabetes care,” Raveendhara Bannuru, M.D., PhD, the ADA’s vice president of medical affairs and quality improvement outcomes in Boston, Massachusetts, told Fox News Digital via email.
“With continuous glucose sensing, glucose control has been dramatically improved,” a doctor told Fox News Digital. (iStock)
“We are hopeful for the continuous development of alternative insulin delivery methods that could offer options for people living with diabetes,” the group also said in the statement.
“The INHALE-3 trial demonstrated that inhaled insulin, combined with insulin degludec, effectively reduces A1c levels without increasing hypoglycemia or weight gain in people with type 1 diabetes. This adds value to the options in insulin therapy.”
Potential risks and limitations
While more people met their glycemic targets with Afrezza, some subjects saw worse readings when switching from usual methods to inhaled insulin — “potentially due to missing doses of inhaled insulin during the day and/or underdosing going into bedtime,” the researchers wrote.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“We didn’t see any concerns,” Hirsch said when asked about side effects.
“As expected, a few people coughed immediately when dosing their insulin, but no major concerns were seen and everyone continued on their inhaled insulin.”
“Not everyone reaches the target with multiple injections or pumps, and there are many pros and cons with each therapy,” a doctor said. (iStock)
The most common side effects noted in the study were hypoglycemia, cough and throat pain or irritation.
Afrezza has been linked to a risk of acute bronchospasm in patients with chronic lung disease, such as asthma or COPD, according to the manufacturer.
“Inhaling insulin isn’t for everyone, but some did better than they did on their pumps.”
Before starting Afrezza, patients should see a doctor for a physical examination and testing to measure lung function.
Patients who smoke or who recently quit smoking should not take the inhaled medication.
For more Health articles, visit www.foxnews/health
Fox News Digital reached out to MannKind requesting additional comment.
L.A. businessman, former mayoral candidate Rick Caruso endorses DA Gascón’s opponent
Living with PFAS in Metro Detroit
Bill Maher sounds alarm on immigration chaos: It'll get Dems 'f—ed on Election Day'
''Everything Is Mega Cheap'': Entrepreneur Shares Perks Of Living In Bengaluru Over San Francisco
2025 NCAA Tournament Projections Has Miami As An Eighth Seed; First Alert: June 25, 2024
See it: Tesla crashes into Columbus convention center at 70 mph
Colorado Rockies game no. 116 thread: Zac Gallen vs José Ureña
Fox News Politics: Georgia the whole day through
Death of missing Oregon girl found in stream ruled homicide
At least 2 dead as tornadoes hit Alabama, damage homes across Southeast
Mike Kennedy advances past crowded GOP primary to secure nomination for open Utah House seat
France elections: Germans prepare for seismic change in EU politics
Iowa floodwaters breach levees as even more rain dumps onto parts of the Midwest
Fox News Politics: Trump Ungagged…Kinda
A right to drink? Inside the debate to protect US workers against the heat
-
News1 week agoIt's easy to believe young voters could back Trump at young conservative conference
-
World1 week agoSwiss summit demands 'territorial integrity' of Ukraine
-
World1 week agoProtesters in Brussels march against right-wing ideology
-
News1 week agoA fast-moving wildfire spreads north of Los Angeles, forcing evacuations
-
World1 week agoAl-Qaeda affiliate claims responsibility for June attack in Burkina Faso
-
Movie Reviews1 week agoShort Film Review: Willow and Wu (2024) by Kathy Meng
-
News1 week agoMass shooting at Rochester Hills splash pad: Everything we know
-
Movie Reviews1 week agoMovie Review: Top 5 Movies to Watch This Father's Day June 16, 2024 –